Comparison of post-lyme borreliosis symptoms in erythema migrans patients with positive and negative borrelia burgdorferi sensu lato skin culture

Vector-Borne and Zoonotic Diseases

Volumn 11, Issue 7, 2011, Pages 883-889

  Stupica, Daša ^a   Lusa, Lara ^b   Cerar, Tjaša ^c   Ružić Sabljić, Eva ^c   Strle, Franc ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

borrelia skin culture; erythema migrans; Lyme borreliosis; skin biopsy

Indexed keywords

CEFUROXIME AXETIL; DOXYCYCLINE;

ADULT; ARTICLE; BACTERIUM CULTURE; BORRELIA AFZELII; BORRELIA BURGDORFERI; BORRELIA GARINII; COMPARATIVE STUDY; CONTROLLED STUDY; ERYTHEMA CHRONICUM MIGRANS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SKIN BIOPSY; SKIN CULTURE; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; ANIMALS; ANTI-BACTERIAL AGENTS; BORRELIA BURGDORFERI; CEFUROXIME; DOXYCYCLINE; FEMALE; GLOSSITIS, BENIGN MIGRATORY; HUMANS; LYME DISEASE; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SKIN; SLOVENIA; TIME FACTORS; TREATMENT OUTCOME;

BORRELIA; BORRELIA AFZELII; BORRELIA BURGDORFERI; BORRELIA BURGDORFERI GROUP; BORRELIA GARINII;

EID: 79960139090     PISSN: 15303667     EISSN: 15577759     Source Type: Journal    
DOI: 10.1089/vbz.2010.0018     Document Type: Article

References (28)

1. [CDC] Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance: Lyme disease (revised 9/96). MMWR Morb Mortal Wkly Rep 1997; 46(Suppl RR-10):20-21
2. Cerar, D, Cerar, T, Ružić-Sabljić, E, Wormser, GP, et al. Controlled prospective study on the development of subjective symptoms after treatment of early Lyme disease in Europe. Am J Med 2010; 123:79-86
3. Dattwyler, RJ, Luft, BJ, Kunkel, MJ, Finkel, MF, et al. Ceftriaxone compared with doxycicline for the treatment of acute disseminated Lyme disease. N Engl J Med 1997; 337:289-294 (Pubitemid 27318989)
4. Dattwyler, RJ, Volkman, DJ, Conaty, SM, Platkin, SP, et al. Amoxicillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis. Lancet 1990; 336:1404-1406
5. Klempner, MS. Controlled trials of antibiotic treatment in patients with post-treatment chronic Lyme disease. Vector Borne Zoonot Dis 2002; 2:255-263
6. Liveris, D, Wang, G, Girao, G, Byrne, DW, et al. Quantitative detection of Borrelia burgdorferi in 2-millimeter skin samples of erythema migrans lesions: Correlation of results with clinical and laboratory findings. J Clin Microbiol 2002; 40:1249-1253 (Pubitemid 34279884)
7. Logar, M, Lotric-Furlan, S, Maraspin, V, Cimperman, J, et al. Has the presence or absence of Borrelia burgdorferi sensu lato as detected by skin culture any influence on the course of erythema migrans? Wien Klin Wochenschr 1999; 111:945-950 (Pubitemid 30026412)
8. Luft, BJ, Dattwyler, RJ, Johnson, RC, Luger, SW, et al. Azithromycin compared with amoxicillin in the treatment of erythema migrans. Ann Intern Med 1996; 124:785-791
9. Luger, SW, Paparone, P, Wormser, GP, Nadelman, RB, et al. Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans. Antimicrob Agents Chemother 1995; 39:661-667
10. Massarotti, EM, Luger, SW, Rahn, DW, Messner, RP, et al. Treatment of early Lyme disease. Am J Med 1992; 92:396-403
11. Nowakowski, J, Nadelman, RB, Sell, R, McKenna, D, et al. Longterm follow-up of patients with culture-confirmed Lyme disease. Am J Med 2003; 115:91-96 (Pubitemid 37288835)
12. Preac-Mursic, V, Wilske, B, Schierz G. European Borrelia burgdorferi isolated from humans and ticks. Culture conditions and antibiotic susceptibility. Zentral Bakteriol Mikrobiol Hyg 1986; 263:112-118 (Pubitemid 17030845)
13. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2009. Available at www.R-project.org
14. Ruzić-Sabljić, E, Maraspin, V, Lotric-Furlan, S, Jurca, T, et al. Characterization of Borrelia burgdorferi sensu lato strains isolated from human material in Slovenia. Wien Klin Wochenschr 2002; 114:544-550 (Pubitemid 34847341)
15. Ruzić-Sabljić, E, Strle, F, Cimperman, J, Maraspin, V, et al. Characterisation of Borrelia burgdorferi sensu lato strains isolated from patients with skin manifestations of Lyme borreliosis residing in Slovenia. J Med Microbiol 2000; 49:47-53 (Pubitemid 30025861)
16. Sigal, LH. Persisting complaints attributed to chronic Lyme disease: possible mechanisms and implications for management. Am J Med 1994; 96:365-374 (Pubitemid 24127274)
17. Stanek, G, Strle F. Lyme borreliosis. Lancet 2003; 362:1639-1647 (Pubitemid 37443533)
18. Steere, AC. Lyme disease. N Engl J Med 2001; 345:115-125 (Pubitemid 32640193)
19. Steere, AC, Bartenhagen, NH, Craft, JE, Hutchinson, GJ, et al. The early clinical manifestations of Lyme disease. Ann Intern Med 1983a; 99:76-82 (Pubitemid 13066663)
20. Steere, AC, Hutchinson, GJ, Rahn, DW, Sigal, LH, et al. Treatment of the early manifestations of Lyme disease. Ann Intern Med 1983b; 99:22-26 (Pubitemid 13066652)
21. Weber, K. Treatment failure in erythema migrans-a review. Infection 1996; 24:73-75 (Pubitemid 26062746)
22. Weber, K, Neubert, U. Clinical features of early erythema migrans disease and related disorders. Zbl Bakt Hyg 1986; A263:209-228 (Pubitemid 17030860)
23. Weber, K, Preac-Mursic, V, Wilske, B, Thurmayr, R, et al. A randomized trial of ceftriaxone versus oral penicillin for the treatment of early European Lyme borreliosis. Infection 1990; 18:91-96 (Pubitemid 20123450)
24. Weber, K, Wilske, B, Preac-Mursic, V, Thurmayr, R. Azithromycin versus penicillin V for the treatment of early Lyme borreliosis. Infection 1993; 21:367-372
25. Wormser, GP, Dattwyler, RJ, Shapiro, ED, Halperin, JJ. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Disease Society of America. Clin Infect Dis 2006; 43:1089-1134 (Pubitemid 44637131)
26. Wormser, GP, Liveris, D, Nowakowski, J, Nadelman, RB, et al. Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early Lyme disease. J Infect Dis 1999; 180:720-725 (Pubitemid 29411358)
27. Wormser, GP, McKenna, D, Carlin, J, Nadelman, RB, et al. Hematogenous dissemination in early Lyme disease. Ann Intern Med 2005; 142:751-755 (Pubitemid 40593777)
28. Wormser, GP, Ramanathan, R, Nowakowski, J, McKenna, D, et al. Duration of antibiotic therapy for early Lyme disease. Ann Intern Med 2003; 138:697-704